Letters to the editor
Creutzfeldt-Jakob-like syndrome induced by lithium, levomepromazine, and phenobarbitone
| The first 150 words of the full text of this article appear below. |
Creutzfeldt-Jakob-like syndrome was first reported by Smith and Kocen1 in 1988. Its symptoms resemble Creutzfeldt-Jakob disease but it is induced by drugs, particularly lithium, and most patients recover without sequel after discontinuation of drugs. It also displays a characteristic EEG similar to Creutzfeldt-Jakob disease, but this returns to normal when the patient recovers.
There have been some case reports of Creutzfeldt-Jakob-like syndrome
after that of Smith et al (table), but no
paper seems to have described the detailed course of EEG changes. This
paper presents a case of Creutzfeldt-Jakob-like syndrome possibly
induced by lithium, levomepromazine, and phenobarbitone, in which we
succeeded in recording the course of EEG changes.
| Table Removed (Available Only in the Full Text) |
A 65 year old woman was admitted to a hospital with coma and myoclonus.
She had a history of manic and depressive disease for 8 years and had
been treated with 200 mg lithium carbonate, 25 mg chlorpomazine, and 10 mg levomepromazine daily. Her first symptom was forgetfulness
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
